STAT3 and neoplasm: Activated STAT3 is positively correlated with poor prognoses in HCC; nuclear tyrosine705-phosphorylated STAT3 (STAT3/Y705-p) was present in 60% of HCC and correlated with tumor progression and poor prognosis [12, 13].